BerandaCYBN • NYSEAMERICAN
add
Cybin Inc
$6,99
Setelah Jam Perdagangan Normal:(1,72%)+0,12
$7,11
Tutup: 25 Apr, 17.05.01 GMT-4 · USD · NYSEAMERICAN · Pernyataan Penyangkalan
Tutup sebelumnya
$7,06
Rentang hari
$6,91 - $7,20
Rentang tahun
$4,81 - $14,44
Volume Rata-Rata
260,03 rb
Rasio P/E
-
Hasil dividen
-
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (CAD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | — | — |
Biaya operasional | 31,33 jt | 15,94% |
Laba bersih | -10,54 jt | 65,24% |
Margin laba bersih | — | — |
Penghasilan per saham | -0,53 | 84,50% |
EBITDA | -31,28 jt | -16,41% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (CAD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 136,29 jt | 249,47% |
Total aset | 253,55 jt | 95,45% |
Total liabilitas | 13,31 jt | 56,49% |
Total ekuitas | 240,24 jt | — |
Saham yang beredar | 21,04 jt | — |
Harga terhadap nilai buku | 0,59 | — |
Tingkat pengembalian aset | -30,36% | — |
Tingkat pengembalian modal | -31,62% | — |
Arus Kas
Perubahan kas bersih
| (CAD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -10,54 jt | 65,24% |
Kas dari operasi | -27,12 jt | -4,15% |
Kas dari investasi | -303,00 rb | -104,06% |
Kas dari pembiayaan | -179,00 rb | -100,45% |
Perubahan kas bersih | -18,03 jt | -186,34% |
Arus kas bebas | -17,34 jt | -88,49% |
Tentang
Cybin IRL is a Canadian pharmaceutical company that is developing psychedelic drugs as medicines.
The company's drug candidates include psilocybin, CYB002, CYB003, CYB004, CYB005, and CYB006. Another drug that the company has developed is CYB210010.
As of January 2025, CYB003 is in phase 3 clinical trials. The drug is one of the only other psychedelics besides Compass Pathways's COMP360 to have reached this late stage of clinical development.
In 2020, Cybin acquired psychedelic pharmaceutical company Adelia Therapeutics. Wikipedia
Didirikan
2019
Kantor pusat
Situs
Karyawan
50
